Poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances (T50)

Browse all the diagnosis codes used for poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances (t50). For easy navigation, the diagnosis codes are sorted in alphabetical order and grouped by sections. Each section is clearly marked with its description, and the corresponding three-digit code range. This format makes it simple to browse diagnosis codes in this chapter or section and find what you're looking for. We've also added green checkmark icons to label billable codes, and red warning icons for non-billable ones. This makes it easy to identify which codes can be billed.

Clinical Information

Acanthosis Nigricans - A circumscribed melanosis consisting of a brown-pigmented, velvety verrucosity or fine papillomatosis appearing in the axillae and other body folds. It occurs in association with endocrine disorders, underlying malignancy, administration of certain drugs, or as in inherited disorder.

Androgen-Insensitivity Syndrome - A disorder of sexual development transmitted as an X-linked recessive trait. These patients have a karyotype of 46,XY with end-organ resistance to androgen due to mutations in the androgen receptor (RECEPTORS, ANDROGEN) gene. Severity of the defect in receptor quantity or quality correlates with their phenotypes. In these genetic males, the phenotypic spectrum ranges from those with normal female external genitalia, through those with genital ambiguity as in Reifenstein Syndrome, to that of a normal male with INFERTILITY.

Appetite Depressants - Agents that are used to suppress appetite.

Bacterial Vaccines - Suspensions of attenuated or killed bacteria administered for the prevention or treatment of infectious bacterial disease.

Dermatomyositis - A subacute or chronic inflammatory disease of muscle and skin, marked by proximal muscle weakness and a characteristic skin rash. The illness occurs with approximately equal frequency in children and adults. The skin lesions usually take the form of a purplish rash (or less often an exfoliative dermatitis) involving the nose, cheeks, forehead, upper trunk, and arms. The disease is associated with a complement mediated intramuscular microangiopathy, leading to loss of capillaries, muscle ischemia, muscle-fiber necrosis, and perifascicular atrophy. The childhood form of this disease tends to evolve into a systemic vasculitis. Dermatomyositis may occur in association with malignant neoplasms. (From Adams et al., Principles of Neurology, 6th ed, pp1405-6)

Drug Tolerance - Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL.

Erythromelalgia - A peripheral arterial disease that is characterized by the triad of ERYTHEMA, burning PAIN, and increased SKIN TEMPERATURE of the extremities (or red, painful extremities). Erythromelalgia may be classified as primary or idiopathic, familial or non-familial. Secondary erythromelalgia is associated with other diseases, the most common being MYELOPROLIFERATIVE DISORDERS.

Feminization - Development of female secondary SEX CHARACTERISTICS in the MALE. It is due to the effects of estrogenic metabolites of precursors from endogenous or exogenous sources, such as ADRENAL GLANDS or therapeutic drugs.

Gynecomastia - Enlargement of the BREAST in the males, caused by an excess of ESTROGENS. Physiological gynecomastia is normally observed in NEWBORNS; ADOLESCENT; and AGING males.

Hirsutism - A condition observed in WOMEN and CHILDREN when there is excess coarse body hair of an adult male distribution pattern, such as facial and chest areas. It is the result of elevated ANDROGENS from the OVARIES, the ADRENAL GLANDS, or exogenous sources. The concept does not include HYPERTRICHOSIS, which is an androgen-independent excessive hair growth.

Hyperkalemia - Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)

Metoclopramide - A dopamine D2 antagonist that is used as an antiemetic.

Onycholysis - Separation of nail plate from the underlying nail bed. It can be a sign of skin disease, infection (such as ONYCHOMYCOSIS) or tissue injury.

Onychomycosis - A fungal infection of the nail, usually caused by DERMATOPHYTES; YEASTS; or nondermatophyte MOLDS.

Ototoxicity - Damage to the EAR or its function secondary to exposure to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

Pellagra - A disease due to deficiency of NIACIN, a B-complex vitamin, or its precursor TRYPTOPHAN. It is characterized by scaly DERMATITIS which is often associated with DIARRHEA and DEMENTIA (the three D's).

Polymyositis - Diseases characterized by inflammation involving multiple muscles. This may occur as an acute or chronic condition associated with medication toxicity (DRUG TOXICITY); CONNECTIVE TISSUE DISEASES; infections; malignant NEOPLASMS; and other disorders. The term polymyositis is frequently used to refer to a specific clinical entity characterized by subacute or slowly progressing symmetrical weakness primarily affecting the proximal limb and trunk muscles. The illness may occur at any age, but is most frequent in the fourth to sixth decade of life. Weakness of pharyngeal and laryngeal muscles, interstitial lung disease, and inflammation of the myocardium may also occur. Muscle biopsy reveals widespread destruction of segments of muscle fibers and an inflammatory cellular response. (Adams et al., Principles of Neurology, 6th ed, pp1404-9)

Priapism - A prolonged painful erection that may lasts hours and is not associated with sexual activity. It is seen in patients with SICKLE CELL ANEMIA, advanced malignancy, spinal trauma; and certain drug treatments.

Pseudohypoaldosteronism - A heterogeneous group of disorders characterized by renal electrolyte transport dysfunctions. Congenital forms are rare autosomal disorders characterized by neonatal hypertension, HYPERKALEMIA, increased RENIN activity and ALDOSTERONE concentration. The Type I features HYPERKALEMIA with sodium wasting; Type II, HYPERKALEMIA without sodium wasting. Pseudohypoaldosteronism can be the result of a defective renal electrolyte transport protein or acquired after KIDNEY TRANSPLANTATION.

Pseudoxanthoma Elasticum - An inherited disorder of connective tissue with extensive degeneration and calcification of ELASTIC TISSUE primarily in the skin, eye, and vasculature. At least two forms exist, autosomal recessive and autosomal dominant. This disorder is caused by mutations of one of the ATP-BINDING CASSETTE TRANSPORTERS. Patients are predisposed to MYOCARDIAL INFARCTION and GASTROINTESTINAL HEMORRHAGE.

Tardive Dyskinesia - Drug-related movement disorder characterized by uncontrollable movements in certain muscles. It is associated with a long-term exposure to certain neuroleptic medications (e.g., METOCLOPRAMIDE).

Torsades de Pointes - A malignant form of polymorphic ventricular tachycardia that is characterized by HEART RATE between 200 and 250 beats per minute, and QRS complexes with changing amplitude and twisting of the points. The term also describes the syndrome of tachycardia with prolonged ventricular repolarization, long QT intervals exceeding 500 milliseconds or BRADYCARDIA. Torsades de pointes may be self-limited or may progress to VENTRICULAR FIBRILLATION.

Toxic Optic Neuropathy - Damage to the eye or its function (e.g., VISUAL IMPAIRMENT) due to OPTIC NERVE damage secondary to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

Viral Vaccines - Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease.

Xerostomia - Decreased salivary flow.

Instructional Notations

7th Character Note

Certain ICD-10-CM categories have applicable 7th characters. The applicable 7th character is required for all codes within the category, or as the notes in the Tabular List instruct. The 7th character must always be the 7th character in the data field. If a code that requires a 7th character is not 6 characters, a placeholder X must be used to fill in the empty characters.

  • The appropriate 7th character is to be added to each code from category T50

7th Character

Indicates that a seventh character is to be assigned to codes in a subcategory.

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela
  • Injury, poisoning and certain other consequences of external causes (S00–T88)

    • Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances (T36-T50)

        • Poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances (T50)

        • T50 Poisoning by, adverse effect of and underdosing of diuretics and other and unspecified drugs, medicaments and biological substances
        • T50.0 Poisoning by, adverse effect of and underdosing of mineralocorticoids and their antagonists
        • T50.0X Poisoning by, adverse effect of and underdosing of mineralocorticoids and their antagonists
        • T50.0X1 Poisoning by mineralocorticoids and their antagonists, accidental (unintentional)
        • T50.0X1A Poisoning by mineralocorticoids and their antagonists, accidental (unintentional), initial encounter
        • T50.0X1D Poisoning by mineralocorticoids and their antagonists, accidental (unintentional), subsequent encounter
        • T50.0X1S Poisoning by mineralocorticoids and their antagonists, accidental (unintentional), sequela
        • T50.0X2 Poisoning by mineralocorticoids and their antagonists, intentional self-harm
        • T50.0X2A Poisoning by mineralocorticoids and their antagonists, intentional self-harm, initial encounter
        • T50.0X2D Poisoning by mineralocorticoids and their antagonists, intentional self-harm, subsequent encounter
        • T50.0X2S Poisoning by mineralocorticoids and their antagonists, intentional self-harm, sequela
        • T50.0X3 Poisoning by mineralocorticoids and their antagonists, assault
        • T50.0X3A Poisoning by mineralocorticoids and their antagonists, assault, initial encounter
        • T50.0X3D Poisoning by mineralocorticoids and their antagonists, assault, subsequent encounter
        • T50.0X3S Poisoning by mineralocorticoids and their antagonists, assault, sequela
        • T50.0X4 Poisoning by mineralocorticoids and their antagonists, undetermined
        • T50.0X4A Poisoning by mineralocorticoids and their antagonists, undetermined, initial encounter
        • T50.0X4D Poisoning by mineralocorticoids and their antagonists, undetermined, subsequent encounter
        • T50.0X4S Poisoning by mineralocorticoids and their antagonists, undetermined, sequela
        • T50.0X5 Adverse effect of mineralocorticoids and their antagonists
        • T50.0X5A Adverse effect of mineralocorticoids and their antagonists, initial encounter
        • T50.0X5D Adverse effect of mineralocorticoids and their antagonists, subsequent encounter
        • T50.0X5S Adverse effect of mineralocorticoids and their antagonists, sequela
        • T50.0X6 Underdosing of mineralocorticoids and their antagonists
        • T50.0X6A Underdosing of mineralocorticoids and their antagonists, initial encounter
        • T50.0X6D Underdosing of mineralocorticoids and their antagonists, subsequent encounter
        • T50.0X6S Underdosing of mineralocorticoids and their antagonists, sequela
        • T50.1 Poisoning by, adverse effect of and underdosing of loop [high-ceiling] diuretics
        • T50.1X Poisoning by, adverse effect of and underdosing of loop [high-ceiling] diuretics
        • T50.1X1 Poisoning by loop [high-ceiling] diuretics, accidental (unintentional)
        • T50.1X1A Poisoning by loop [high-ceiling] diuretics, accidental (unintentional), initial encounter
        • T50.1X1D Poisoning by loop [high-ceiling] diuretics, accidental (unintentional), subsequent encounter
        • T50.1X1S Poisoning by loop [high-ceiling] diuretics, accidental (unintentional), sequela
        • T50.1X2 Poisoning by loop [high-ceiling] diuretics, intentional self-harm
        • T50.1X2A Poisoning by loop [high-ceiling] diuretics, intentional self-harm, initial encounter
        • T50.1X2D Poisoning by loop [high-ceiling] diuretics, intentional self-harm, subsequent encounter
        • T50.1X2S Poisoning by loop [high-ceiling] diuretics, intentional self-harm, sequela
        • T50.1X3 Poisoning by loop [high-ceiling] diuretics, assault
        • T50.1X3A Poisoning by loop [high-ceiling] diuretics, assault, initial encounter
        • T50.1X3D Poisoning by loop [high-ceiling] diuretics, assault, subsequent encounter
        • T50.1X3S Poisoning by loop [high-ceiling] diuretics, assault, sequela
        • T50.1X4 Poisoning by loop [high-ceiling] diuretics, undetermined
        • T50.1X4A Poisoning by loop [high-ceiling] diuretics, undetermined, initial encounter
        • T50.1X4D Poisoning by loop [high-ceiling] diuretics, undetermined, subsequent encounter
        • T50.1X4S Poisoning by loop [high-ceiling] diuretics, undetermined, sequela
        • T50.1X5 Adverse effect of loop [high-ceiling] diuretics
        • T50.1X5A Adverse effect of loop [high-ceiling] diuretics, initial encounter
        • T50.1X5D Adverse effect of loop [high-ceiling] diuretics, subsequent encounter
        • T50.1X5S Adverse effect of loop [high-ceiling] diuretics, sequela
        • T50.1X6 Underdosing of loop [high-ceiling] diuretics
        • T50.1X6A Underdosing of loop [high-ceiling] diuretics, initial encounter
        • T50.1X6D Underdosing of loop [high-ceiling] diuretics, subsequent encounter
        • T50.1X6S Underdosing of loop [high-ceiling] diuretics, sequela
        • T50.2 Poisoning by, adverse effect of and underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
        • T50.2X Poisoning by, adverse effect of and underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
        • T50.2X1 Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional)
        • T50.2X1A Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), initial encounter
        • T50.2X1D Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), subsequent encounter
        • T50.2X1S Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, accidental (unintentional), sequela
        • T50.2X2 Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm
        • T50.2X2A Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, initial encounter
        • T50.2X2D Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, subsequent encounter
        • T50.2X2S Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, intentional self-harm, sequela
        • T50.2X3 Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault
        • T50.2X3A Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, initial encounter
        • T50.2X3D Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, subsequent encounter
        • T50.2X3S Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, assault, sequela
        • T50.2X4 Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined
        • T50.2X4A Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, initial encounter
        • T50.2X4D Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, subsequent encounter
        • T50.2X4S Poisoning by carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, undetermined, sequela
        • T50.2X5 Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
        • T50.2X5A Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
        • T50.2X5D Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
        • T50.2X5S Adverse effect of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
        • T50.2X6 Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics
        • T50.2X6A Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, initial encounter
        • T50.2X6D Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, subsequent encounter
        • T50.2X6S Underdosing of carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics, sequela
        • T50.3 Poisoning by, adverse effect of and underdosing of electrolytic, caloric and water-balance agents
        • T50.3X Poisoning by, adverse effect of and underdosing of electrolytic, caloric and water-balance agents
        • T50.3X1 Poisoning by electrolytic, caloric and water-balance agents, accidental (unintentional)
        • T50.3X1A Poisoning by electrolytic, caloric and water-balance agents, accidental (unintentional), initial encounter
        • T50.3X1D Poisoning by electrolytic, caloric and water-balance agents, accidental (unintentional), subsequent encounter
        • T50.3X1S Poisoning by electrolytic, caloric and water-balance agents, accidental (unintentional), sequela
        • T50.3X2 Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm
        • T50.3X2A Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm, initial encounter
        • T50.3X2D Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm, subsequent encounter
        • T50.3X2S Poisoning by electrolytic, caloric and water-balance agents, intentional self-harm, sequela
        • T50.3X3 Poisoning by electrolytic, caloric and water-balance agents, assault
        • T50.3X3A Poisoning by electrolytic, caloric and water-balance agents, assault, initial encounter
        • T50.3X3D Poisoning by electrolytic, caloric and water-balance agents, assault, subsequent encounter
        • T50.3X3S Poisoning by electrolytic, caloric and water-balance agents, assault, sequela
        • T50.3X4 Poisoning by electrolytic, caloric and water-balance agents, undetermined
        • T50.3X4A Poisoning by electrolytic, caloric and water-balance agents, undetermined, initial encounter
        • T50.3X4D Poisoning by electrolytic, caloric and water-balance agents, undetermined, subsequent encounter
        • T50.3X4S Poisoning by electrolytic, caloric and water-balance agents, undetermined, sequela
        • T50.3X5 Adverse effect of electrolytic, caloric and water-balance agents
        • T50.3X5A Adverse effect of electrolytic, caloric and water-balance agents, initial encounter
        • T50.3X5D Adverse effect of electrolytic, caloric and water-balance agents, subsequent encounter
        • T50.3X5S Adverse effect of electrolytic, caloric and water-balance agents, sequela
        • T50.3X6 Underdosing of electrolytic, caloric and water-balance agents
        • T50.3X6A Underdosing of electrolytic, caloric and water-balance agents, initial encounter
        • T50.3X6D Underdosing of electrolytic, caloric and water-balance agents, subsequent encounter
        • T50.3X6S Underdosing of electrolytic, caloric and water-balance agents, sequela
        • T50.4 Poisoning by, adverse effect of and underdosing of drugs affecting uric acid metabolism
        • T50.4X Poisoning by, adverse effect of and underdosing of drugs affecting uric acid metabolism
        • T50.4X1 Poisoning by drugs affecting uric acid metabolism, accidental (unintentional)
        • T50.4X1A Poisoning by drugs affecting uric acid metabolism, accidental (unintentional), initial encounter
        • T50.4X1D Poisoning by drugs affecting uric acid metabolism, accidental (unintentional), subsequent encounter
        • T50.4X1S Poisoning by drugs affecting uric acid metabolism, accidental (unintentional), sequela
        • T50.4X2 Poisoning by drugs affecting uric acid metabolism, intentional self-harm
        • T50.4X2A Poisoning by drugs affecting uric acid metabolism, intentional self-harm, initial encounter
        • T50.4X2D Poisoning by drugs affecting uric acid metabolism, intentional self-harm, subsequent encounter
        • T50.4X2S Poisoning by drugs affecting uric acid metabolism, intentional self-harm, sequela
        • T50.4X3 Poisoning by drugs affecting uric acid metabolism, assault
        • T50.4X3A Poisoning by drugs affecting uric acid metabolism, assault, initial encounter
        • T50.4X3D Poisoning by drugs affecting uric acid metabolism, assault, subsequent encounter
        • T50.4X3S Poisoning by drugs affecting uric acid metabolism, assault, sequela
        • T50.4X4 Poisoning by drugs affecting uric acid metabolism, undetermined
        • T50.4X4A Poisoning by drugs affecting uric acid metabolism, undetermined, initial encounter
        • T50.4X4D Poisoning by drugs affecting uric acid metabolism, undetermined, subsequent encounter
        • T50.4X4S Poisoning by drugs affecting uric acid metabolism, undetermined, sequela
        • T50.4X5 Adverse effect of drugs affecting uric acid metabolism
        • T50.4X5A Adverse effect of drugs affecting uric acid metabolism, initial encounter
        • T50.4X5D Adverse effect of drugs affecting uric acid metabolism, subsequent encounter
        • T50.4X5S Adverse effect of drugs affecting uric acid metabolism, sequela
        • T50.4X6 Underdosing of drugs affecting uric acid metabolism
        • T50.4X6A Underdosing of drugs affecting uric acid metabolism, initial encounter
        • T50.4X6D Underdosing of drugs affecting uric acid metabolism, subsequent encounter
        • T50.4X6S Underdosing of drugs affecting uric acid metabolism, sequela
        • T50.5 Poisoning by, adverse effect of and underdosing of appetite depressants
        • T50.5X Poisoning by, adverse effect of and underdosing of appetite depressants
        • T50.5X1 Poisoning by appetite depressants, accidental (unintentional)
        • T50.5X1A Poisoning by appetite depressants, accidental (unintentional), initial encounter
        • T50.5X1D Poisoning by appetite depressants, accidental (unintentional), subsequent encounter
        • T50.5X1S Poisoning by appetite depressants, accidental (unintentional), sequela
        • T50.5X2 Poisoning by appetite depressants, intentional self-harm
        • T50.5X2A Poisoning by appetite depressants, intentional self-harm, initial encounter
        • T50.5X2D Poisoning by appetite depressants, intentional self-harm, subsequent encounter
        • T50.5X2S Poisoning by appetite depressants, intentional self-harm, sequela
        • T50.5X3 Poisoning by appetite depressants, assault
        • T50.5X3A Poisoning by appetite depressants, assault, initial encounter
        • T50.5X3D Poisoning by appetite depressants, assault, subsequent encounter
        • T50.5X3S Poisoning by appetite depressants, assault, sequela
        • T50.5X4 Poisoning by appetite depressants, undetermined
        • T50.5X4A Poisoning by appetite depressants, undetermined, initial encounter
        • T50.5X4D Poisoning by appetite depressants, undetermined, subsequent encounter
        • T50.5X4S Poisoning by appetite depressants, undetermined, sequela
        • T50.5X5 Adverse effect of appetite depressants
        • T50.5X5A Adverse effect of appetite depressants, initial encounter
        • T50.5X5D Adverse effect of appetite depressants, subsequent encounter
        • T50.5X5S Adverse effect of appetite depressants, sequela
        • T50.5X6 Underdosing of appetite depressants
        • T50.5X6A Underdosing of appetite depressants, initial encounter
        • T50.5X6D Underdosing of appetite depressants, subsequent encounter
        • T50.5X6S Underdosing of appetite depressants, sequela
        • T50.6 Poisoning by, adverse effect of and underdosing of antidotes and chelating agents
        • T50.6X Poisoning by, adverse effect of and underdosing of antidotes and chelating agents
        • T50.6X1 Poisoning by antidotes and chelating agents, accidental (unintentional)
        • T50.6X1A Poisoning by antidotes and chelating agents, accidental (unintentional), initial encounter
        • T50.6X1D Poisoning by antidotes and chelating agents, accidental (unintentional), subsequent encounter
        • T50.6X1S Poisoning by antidotes and chelating agents, accidental (unintentional), sequela
        • T50.6X2 Poisoning by antidotes and chelating agents, intentional self-harm
        • T50.6X2A Poisoning by antidotes and chelating agents, intentional self-harm, initial encounter
        • T50.6X2D Poisoning by antidotes and chelating agents, intentional self-harm, subsequent encounter
        • T50.6X2S Poisoning by antidotes and chelating agents, intentional self-harm, sequela
        • T50.6X3 Poisoning by antidotes and chelating agents, assault
        • T50.6X3A Poisoning by antidotes and chelating agents, assault, initial encounter
        • T50.6X3D Poisoning by antidotes and chelating agents, assault, subsequent encounter
        • T50.6X3S Poisoning by antidotes and chelating agents, assault, sequela
        • T50.6X4 Poisoning by antidotes and chelating agents, undetermined
        • T50.6X4A Poisoning by antidotes and chelating agents, undetermined, initial encounter
        • T50.6X4D Poisoning by antidotes and chelating agents, undetermined, subsequent encounter
        • T50.6X4S Poisoning by antidotes and chelating agents, undetermined, sequela
        • T50.6X5 Adverse effect of antidotes and chelating agents
        • T50.6X5A Adverse effect of antidotes and chelating agents, initial encounter
        • T50.6X5D Adverse effect of antidotes and chelating agents, subsequent encounter
        • T50.6X5S Adverse effect of antidotes and chelating agents, sequela
        • T50.6X6 Underdosing of antidotes and chelating agents
        • T50.6X6A Underdosing of antidotes and chelating agents, initial encounter
        • T50.6X6D Underdosing of antidotes and chelating agents, subsequent encounter
        • T50.6X6S Underdosing of antidotes and chelating agents, sequela
        • T50.7 Poisoning by, adverse effect of and underdosing of analeptics and opioid receptor antagonists
        • T50.7X Poisoning by, adverse effect of and underdosing of analeptics and opioid receptor antagonists
        • T50.7X1 Poisoning by analeptics and opioid receptor antagonists, accidental (unintentional)
        • T50.7X1A Poisoning by analeptics and opioid receptor antagonists, accidental (unintentional), initial encounter
        • T50.7X1D Poisoning by analeptics and opioid receptor antagonists, accidental (unintentional), subsequent encounter
        • T50.7X1S Poisoning by analeptics and opioid receptor antagonists, accidental (unintentional), sequela
        • T50.7X2 Poisoning by analeptics and opioid receptor antagonists, intentional self-harm
        • T50.7X2A Poisoning by analeptics and opioid receptor antagonists, intentional self-harm, initial encounter
        • T50.7X2D Poisoning by analeptics and opioid receptor antagonists, intentional self-harm, subsequent encounter
        • T50.7X2S Poisoning by analeptics and opioid receptor antagonists, intentional self-harm, sequela
        • T50.7X3 Poisoning by analeptics and opioid receptor antagonists, assault
        • T50.7X3A Poisoning by analeptics and opioid receptor antagonists, assault, initial encounter
        • T50.7X3D Poisoning by analeptics and opioid receptor antagonists, assault, subsequent encounter
        • T50.7X3S Poisoning by analeptics and opioid receptor antagonists, assault, sequela
        • T50.7X4 Poisoning by analeptics and opioid receptor antagonists, undetermined
        • T50.7X4A Poisoning by analeptics and opioid receptor antagonists, undetermined, initial encounter
        • T50.7X4D Poisoning by analeptics and opioid receptor antagonists, undetermined, subsequent encounter
        • T50.7X4S Poisoning by analeptics and opioid receptor antagonists, undetermined, sequela
        • T50.7X5 Adverse effect of analeptics and opioid receptor antagonists
        • T50.7X5A Adverse effect of analeptics and opioid receptor antagonists, initial encounter
        • T50.7X5D Adverse effect of analeptics and opioid receptor antagonists, subsequent encounter
        • T50.7X5S Adverse effect of analeptics and opioid receptor antagonists, sequela
        • T50.7X6 Underdosing of analeptics and opioid receptor antagonists
        • T50.7X6A Underdosing of analeptics and opioid receptor antagonists, initial encounter
        • T50.7X6D Underdosing of analeptics and opioid receptor antagonists, subsequent encounter
        • T50.7X6S Underdosing of analeptics and opioid receptor antagonists, sequela
        • T50.8 Poisoning by, adverse effect of and underdosing of diagnostic agents
        • T50.8X Poisoning by, adverse effect of and underdosing of diagnostic agents
        • T50.8X1 Poisoning by diagnostic agents, accidental (unintentional)
        • T50.8X1A Poisoning by diagnostic agents, accidental (unintentional), initial encounter
        • T50.8X1D Poisoning by diagnostic agents, accidental (unintentional), subsequent encounter
        • T50.8X1S Poisoning by diagnostic agents, accidental (unintentional), sequela
        • T50.8X2 Poisoning by diagnostic agents, intentional self-harm
        • T50.8X2A Poisoning by diagnostic agents, intentional self-harm, initial encounter
        • T50.8X2D Poisoning by diagnostic agents, intentional self-harm, subsequent encounter
        • T50.8X2S Poisoning by diagnostic agents, intentional self-harm, sequela
        • T50.8X3 Poisoning by diagnostic agents, assault
        • T50.8X3A Poisoning by diagnostic agents, assault, initial encounter
        • T50.8X3D Poisoning by diagnostic agents, assault, subsequent encounter
        • T50.8X3S Poisoning by diagnostic agents, assault, sequela
        • T50.8X4 Poisoning by diagnostic agents, undetermined
        • T50.8X4A Poisoning by diagnostic agents, undetermined, initial encounter
        • T50.8X4D Poisoning by diagnostic agents, undetermined, subsequent encounter
        • T50.8X4S Poisoning by diagnostic agents, undetermined, sequela
        • T50.8X5 Adverse effect of diagnostic agents
        • T50.8X5A Adverse effect of diagnostic agents, initial encounter
        • T50.8X5D Adverse effect of diagnostic agents, subsequent encounter
        • T50.8X5S Adverse effect of diagnostic agents, sequela
        • T50.8X6 Underdosing of diagnostic agents
        • T50.8X6A Underdosing of diagnostic agents, initial encounter
        • T50.8X6D Underdosing of diagnostic agents, subsequent encounter
        • T50.8X6S Underdosing of diagnostic agents, sequela
        • T50.9 Poisoning by, adverse effect of and underdosing of other and unspecified drugs, medicaments and biological substances
        • T50.90 Poisoning by, adverse effect of and underdosing of unspecified drugs, medicaments and biological substances
        • T50.901 Poisoning by unspecified drugs, medicaments and biological substances, accidental (unintentional)
        • T50.901A Poisoning by unspecified drugs, medicaments and biological substances, accidental (unintentional), initial encounter
        • T50.901D Poisoning by unspecified drugs, medicaments and biological substances, accidental (unintentional), subsequent encounter
        • T50.901S Poisoning by unspecified drugs, medicaments and biological substances, accidental (unintentional), sequela
        • T50.902 Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm
        • T50.902A Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm, initial encounter
        • T50.902D Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm, subsequent encounter
        • T50.902S Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm, sequela
        • T50.903 Poisoning by unspecified drugs, medicaments and biological substances, assault
        • T50.903A Poisoning by unspecified drugs, medicaments and biological substances, assault, initial encounter
        • T50.903D Poisoning by unspecified drugs, medicaments and biological substances, assault, subsequent encounter
        • T50.903S Poisoning by unspecified drugs, medicaments and biological substances, assault, sequela
        • T50.904 Poisoning by unspecified drugs, medicaments and biological substances, undetermined
        • T50.904A Poisoning by unspecified drugs, medicaments and biological substances, undetermined, initial encounter
        • T50.904D Poisoning by unspecified drugs, medicaments and biological substances, undetermined, subsequent encounter
        • T50.904S Poisoning by unspecified drugs, medicaments and biological substances, undetermined, sequela
        • T50.905 Adverse effect of unspecified drugs, medicaments and biological substances
        • T50.905A Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter
        • T50.905D Adverse effect of unspecified drugs, medicaments and biological substances, subsequent encounter
        • T50.905S Adverse effect of unspecified drugs, medicaments and biological substances, sequela
        • T50.906 Underdosing of unspecified drugs, medicaments and biological substances
        • T50.906A Underdosing of unspecified drugs, medicaments and biological substances, initial encounter
        • T50.906D Underdosing of unspecified drugs, medicaments and biological substances, subsequent encounter
        • T50.906S Underdosing of unspecified drugs, medicaments and biological substances, sequela
        • T50.91 Poisoning by, adverse effect of and underdosing of multiple unspecified drugs, medicaments and biological substances
        • T50.911 Poisoning by multiple unspecified drugs, medicaments and biological substances, accidental (unintentional)
        • T50.911A Poisoning by multiple unspecified drugs, medicaments and biological substances, accidental (unintentional), initial encounter
        • T50.911D Poisoning by multiple unspecified drugs, medicaments and biological substances, accidental (unintentional), subsequent encounter
        • T50.911S Poisoning by multiple unspecified drugs, medicaments and biological substances, accidental (unintentional), sequela
        • T50.912 Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm
        • T50.912A Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm, initial encounter
        • T50.912D Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm, subsequent encounter
        • T50.912S Poisoning by multiple unspecified drugs, medicaments and biological substances, intentional self-harm, sequela
        • T50.913 Poisoning by multiple unspecified drugs, medicaments and biological substances, assault
        • T50.913A Poisoning by multiple unspecified drugs, medicaments and biological substances, assault, initial encounter
        • T50.913D Poisoning by multiple unspecified drugs, medicaments and biological substances, assault, subsequent encounter
        • T50.913S Poisoning by multiple unspecified drugs, medicaments and biological substances, assault, sequela
        • T50.914 Poisoning by multiple unspecified drugs, medicaments and biological substances, undetermined
        • T50.914A Poisoning by multiple unspecified drugs, medicaments and biological substances, undetermined, initial encounter
        • T50.914D Poisoning by multiple unspecified drugs, medicaments and biological substances, undetermined, subsequent encounter
        • T50.914S Poisoning by multiple unspecified drugs, medicaments and biological substances, undetermined, sequela
        • T50.915 Adverse effect of multiple unspecified drugs, medicaments and biological substances
        • T50.915A Adverse effect of multiple unspecified drugs, medicaments and biological substances, initial encounter
        • T50.915D Adverse effect of multiple unspecified drugs, medicaments and biological substances, subsequent encounter
        • T50.915S Adverse effect of multiple unspecified drugs, medicaments and biological substances, sequela
        • T50.916 Underdosing of multiple unspecified drugs, medicaments and biological substances
        • T50.916A Underdosing of multiple unspecified drugs, medicaments and biological substances, initial encounter
        • T50.916D Underdosing of multiple unspecified drugs, medicaments and biological substances, subsequent encounter
        • T50.916S Underdosing of multiple unspecified drugs, medicaments and biological substances, sequela
        • T50.99 Poisoning by, adverse effect of and underdosing of other drugs, medicaments and biological substances
        • T50.991 Poisoning by other drugs, medicaments and biological substances, accidental (unintentional)
        • T50.991A Poisoning by other drugs, medicaments and biological substances, accidental (unintentional), initial encounter
        • T50.991D Poisoning by other drugs, medicaments and biological substances, accidental (unintentional), subsequent encounter
        • T50.991S Poisoning by other drugs, medicaments and biological substances, accidental (unintentional), sequela
        • T50.992 Poisoning by other drugs, medicaments and biological substances, intentional self-harm
        • T50.992A Poisoning by other drugs, medicaments and biological substances, intentional self-harm, initial encounter
        • T50.992D Poisoning by other drugs, medicaments and biological substances, intentional self-harm, subsequent encounter
        • T50.992S Poisoning by other drugs, medicaments and biological substances, intentional self-harm, sequela
        • T50.993 Poisoning by other drugs, medicaments and biological substances, assault
        • T50.993A Poisoning by other drugs, medicaments and biological substances, assault, initial encounter
        • T50.993D Poisoning by other drugs, medicaments and biological substances, assault, subsequent encounter
        • T50.993S Poisoning by other drugs, medicaments and biological substances, assault, sequela
        • T50.994 Poisoning by other drugs, medicaments and biological substances, undetermined
        • T50.994A Poisoning by other drugs, medicaments and biological substances, undetermined, initial encounter
        • T50.994D Poisoning by other drugs, medicaments and biological substances, undetermined, subsequent encounter
        • T50.994S Poisoning by other drugs, medicaments and biological substances, undetermined, sequela
        • T50.995 Adverse effect of other drugs, medicaments and biological substances
        • T50.995A Adverse effect of other drugs, medicaments and biological substances, initial encounter
        • T50.995D Adverse effect of other drugs, medicaments and biological substances, subsequent encounter
        • T50.995S Adverse effect of other drugs, medicaments and biological substances, sequela
        • T50.996 Underdosing of other drugs, medicaments and biological substances
        • T50.996A Underdosing of other drugs, medicaments and biological substances, initial encounter
        • T50.996D Underdosing of other drugs, medicaments and biological substances, subsequent encounter
        • T50.996S Underdosing of other drugs, medicaments and biological substances, sequela
        • T50.A Poisoning by, adverse effect of and underdosing of bacterial vaccines
        • T50.A1 Poisoning by, adverse effect of and underdosing of pertussis vaccine, including combinations with a pertussis component
        • T50.A11 Poisoning by pertussis vaccine, including combinations with a pertussis component, accidental (unintentional)
        • T50.A11A Poisoning by pertussis vaccine, including combinations with a pertussis component, accidental (unintentional), initial encounter
        • T50.A11D Poisoning by pertussis vaccine, including combinations with a pertussis component, accidental (unintentional), subsequent encounter
        • T50.A11S Poisoning by pertussis vaccine, including combinations with a pertussis component, accidental (unintentional), sequela
        • T50.A12 Poisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm
        • T50.A12A Poisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm, initial encounter
        • T50.A12D Poisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm, subsequent encounter
        • T50.A12S Poisoning by pertussis vaccine, including combinations with a pertussis component, intentional self-harm, sequela
        • T50.A13 Poisoning by pertussis vaccine, including combinations with a pertussis component, assault
        • T50.A13A Poisoning by pertussis vaccine, including combinations with a pertussis component, assault, initial encounter
        • T50.A13D Poisoning by pertussis vaccine, including combinations with a pertussis component, assault, subsequent encounter
        • T50.A13S Poisoning by pertussis vaccine, including combinations with a pertussis component, assault, sequela
        • T50.A14 Poisoning by pertussis vaccine, including combinations with a pertussis component, undetermined
        • T50.A14A Poisoning by pertussis vaccine, including combinations with a pertussis component, undetermined, initial encounter
        • T50.A14D Poisoning by pertussis vaccine, including combinations with a pertussis component, undetermined, subsequent encounter
        • T50.A14S Poisoning by pertussis vaccine, including combinations with a pertussis component, undetermined, sequela
        • T50.A15 Adverse effect of pertussis vaccine, including combinations with a pertussis component
        • T50.A15A Adverse effect of pertussis vaccine, including combinations with a pertussis component, initial encounter
        • T50.A15D Adverse effect of pertussis vaccine, including combinations with a pertussis component, subsequent encounter
        • T50.A15S Adverse effect of pertussis vaccine, including combinations with a pertussis component, sequela
        • T50.A16 Underdosing of pertussis vaccine, including combinations with a pertussis component
        • T50.A16A Underdosing of pertussis vaccine, including combinations with a pertussis component, initial encounter
        • T50.A16D Underdosing of pertussis vaccine, including combinations with a pertussis component, subsequent encounter
        • T50.A16S Underdosing of pertussis vaccine, including combinations with a pertussis component, sequela
        • T50.A2 Poisoning by, adverse effect of and underdosing of mixed bacterial vaccines without a pertussis component
        • T50.A21 Poisoning by mixed bacterial vaccines without a pertussis component, accidental (unintentional)
        • T50.A21A Poisoning by mixed bacterial vaccines without a pertussis component, accidental (unintentional), initial encounter
        • T50.A21D Poisoning by mixed bacterial vaccines without a pertussis component, accidental (unintentional), subsequent encounter
        • T50.A21S Poisoning by mixed bacterial vaccines without a pertussis component, accidental (unintentional), sequela
        • T50.A22 Poisoning by mixed bacterial vaccines without a pertussis component, intentional self-harm
        • T50.A22A Poisoning by mixed bacterial vaccines without a pertussis component, intentional self-harm, initial encounter
        • T50.A22D Poisoning by mixed bacterial vaccines without a pertussis component, intentional self-harm, subsequent encounter
        • T50.A22S Poisoning by mixed bacterial vaccines without a pertussis component, intentional self-harm, sequela
        • T50.A23 Poisoning by mixed bacterial vaccines without a pertussis component, assault
        • T50.A23A Poisoning by mixed bacterial vaccines without a pertussis component, assault, initial encounter
        • T50.A23D Poisoning by mixed bacterial vaccines without a pertussis component, assault, subsequent encounter
        • T50.A23S Poisoning by mixed bacterial vaccines without a pertussis component, assault, sequela
        • T50.A24 Poisoning by mixed bacterial vaccines without a pertussis component, undetermined
        • T50.A24A Poisoning by mixed bacterial vaccines without a pertussis component, undetermined, initial encounter
        • T50.A24D Poisoning by mixed bacterial vaccines without a pertussis component, undetermined, subsequent encounter
        • T50.A24S Poisoning by mixed bacterial vaccines without a pertussis component, undetermined, sequela
        • T50.A25 Adverse effect of mixed bacterial vaccines without a pertussis component
        • T50.A25A Adverse effect of mixed bacterial vaccines without a pertussis component, initial encounter
        • T50.A25D Adverse effect of mixed bacterial vaccines without a pertussis component, subsequent encounter
        • T50.A25S Adverse effect of mixed bacterial vaccines without a pertussis component, sequela
        • T50.A26 Underdosing of mixed bacterial vaccines without a pertussis component
        • T50.A26A Underdosing of mixed bacterial vaccines without a pertussis component, initial encounter
        • T50.A26D Underdosing of mixed bacterial vaccines without a pertussis component, subsequent encounter
        • T50.A26S Underdosing of mixed bacterial vaccines without a pertussis component, sequela
        • T50.A9 Poisoning by, adverse effect of and underdosing of other bacterial vaccines
        • T50.A91 Poisoning by other bacterial vaccines, accidental (unintentional)
        • T50.A91A Poisoning by other bacterial vaccines, accidental (unintentional), initial encounter
        • T50.A91D Poisoning by other bacterial vaccines, accidental (unintentional), subsequent encounter
        • T50.A91S Poisoning by other bacterial vaccines, accidental (unintentional), sequela
        • T50.A92 Poisoning by other bacterial vaccines, intentional self-harm
        • T50.A92A Poisoning by other bacterial vaccines, intentional self-harm, initial encounter
        • T50.A92D Poisoning by other bacterial vaccines, intentional self-harm, subsequent encounter
        • T50.A92S Poisoning by other bacterial vaccines, intentional self-harm, sequela
        • T50.A93 Poisoning by other bacterial vaccines, assault
        • T50.A93A Poisoning by other bacterial vaccines, assault, initial encounter
        • T50.A93D Poisoning by other bacterial vaccines, assault, subsequent encounter
        • T50.A93S Poisoning by other bacterial vaccines, assault, sequela
        • T50.A94 Poisoning by other bacterial vaccines, undetermined
        • T50.A94A Poisoning by other bacterial vaccines, undetermined, initial encounter
        • T50.A94D Poisoning by other bacterial vaccines, undetermined, subsequent encounter
        • T50.A94S Poisoning by other bacterial vaccines, undetermined, sequela
        • T50.A95 Adverse effect of other bacterial vaccines
        • T50.A95A Adverse effect of other bacterial vaccines, initial encounter
        • T50.A95D Adverse effect of other bacterial vaccines, subsequent encounter
        • T50.A95S Adverse effect of other bacterial vaccines, sequela
        • T50.A96 Underdosing of other bacterial vaccines
        • T50.A96A Underdosing of other bacterial vaccines, initial encounter
        • T50.A96D Underdosing of other bacterial vaccines, subsequent encounter
        • T50.A96S Underdosing of other bacterial vaccines, sequela
        • T50.B Poisoning by, adverse effect of and underdosing of viral vaccines
        • T50.B1 Poisoning by, adverse effect of and underdosing of smallpox vaccines
        • T50.B11 Poisoning by smallpox vaccines, accidental (unintentional)
        • T50.B11A Poisoning by smallpox vaccines, accidental (unintentional), initial encounter
        • T50.B11D Poisoning by smallpox vaccines, accidental (unintentional), subsequent encounter
        • T50.B11S Poisoning by smallpox vaccines, accidental (unintentional), sequela
        • T50.B12 Poisoning by smallpox vaccines, intentional self-harm
        • T50.B12A Poisoning by smallpox vaccines, intentional self-harm, initial encounter
        • T50.B12D Poisoning by smallpox vaccines, intentional self-harm, subsequent encounter
        • T50.B12S Poisoning by smallpox vaccines, intentional self-harm, sequela
        • T50.B13 Poisoning by smallpox vaccines, assault
        • T50.B13A Poisoning by smallpox vaccines, assault, initial encounter
        • T50.B13D Poisoning by smallpox vaccines, assault, subsequent encounter
        • T50.B13S Poisoning by smallpox vaccines, assault, sequela
        • T50.B14 Poisoning by smallpox vaccines, undetermined
        • T50.B14A Poisoning by smallpox vaccines, undetermined, initial encounter
        • T50.B14D Poisoning by smallpox vaccines, undetermined, subsequent encounter
        • T50.B14S Poisoning by smallpox vaccines, undetermined, sequela
        • T50.B15 Adverse effect of smallpox vaccines
        • T50.B15A Adverse effect of smallpox vaccines, initial encounter
        • T50.B15D Adverse effect of smallpox vaccines, subsequent encounter
        • T50.B15S Adverse effect of smallpox vaccines, sequela
        • T50.B16 Underdosing of smallpox vaccines
        • T50.B16A Underdosing of smallpox vaccines, initial encounter
        • T50.B16D Underdosing of smallpox vaccines, subsequent encounter
        • T50.B16S Underdosing of smallpox vaccines, sequela
        • T50.B9 Poisoning by, adverse effect of and underdosing of other viral vaccines
        • T50.B91 Poisoning by other viral vaccines, accidental (unintentional)
        • T50.B91A Poisoning by other viral vaccines, accidental (unintentional), initial encounter
        • T50.B91D Poisoning by other viral vaccines, accidental (unintentional), subsequent encounter
        • T50.B91S Poisoning by other viral vaccines, accidental (unintentional), sequela
        • T50.B92 Poisoning by other viral vaccines, intentional self-harm
        • T50.B92A Poisoning by other viral vaccines, intentional self-harm, initial encounter
        • T50.B92D Poisoning by other viral vaccines, intentional self-harm, subsequent encounter
        • T50.B92S Poisoning by other viral vaccines, intentional self-harm, sequela
        • T50.B93 Poisoning by other viral vaccines, assault
        • T50.B93A Poisoning by other viral vaccines, assault, initial encounter
        • T50.B93D Poisoning by other viral vaccines, assault, subsequent encounter
        • T50.B93S Poisoning by other viral vaccines, assault, sequela
        • T50.B94 Poisoning by other viral vaccines, undetermined
        • T50.B94A Poisoning by other viral vaccines, undetermined, initial encounter
        • T50.B94D Poisoning by other viral vaccines, undetermined, subsequent encounter
        • T50.B94S Poisoning by other viral vaccines, undetermined, sequela
        • T50.B95 Adverse effect of other viral vaccines
        • T50.B95A Adverse effect of other viral vaccines, initial encounter
        • T50.B95D Adverse effect of other viral vaccines, subsequent encounter
        • T50.B95S Adverse effect of other viral vaccines, sequela
        • T50.B96 Underdosing of other viral vaccines
        • T50.B96A Underdosing of other viral vaccines, initial encounter
        • T50.B96D Underdosing of other viral vaccines, subsequent encounter
        • T50.B96S Underdosing of other viral vaccines, sequela
        • T50.Z Poisoning by, adverse effect of and underdosing of other vaccines and biological substances
        • T50.Z1 Poisoning by, adverse effect of and underdosing of immunoglobulin
        • T50.Z11 Poisoning by immunoglobulin, accidental (unintentional)
        • T50.Z11A Poisoning by immunoglobulin, accidental (unintentional), initial encounter
        • T50.Z11D Poisoning by immunoglobulin, accidental (unintentional), subsequent encounter
        • T50.Z11S Poisoning by immunoglobulin, accidental (unintentional), sequela
        • T50.Z12 Poisoning by immunoglobulin, intentional self-harm
        • T50.Z12A Poisoning by immunoglobulin, intentional self-harm, initial encounter
        • T50.Z12D Poisoning by immunoglobulin, intentional self-harm, subsequent encounter
        • T50.Z12S Poisoning by immunoglobulin, intentional self-harm, sequela
        • T50.Z13 Poisoning by immunoglobulin, assault
        • T50.Z13A Poisoning by immunoglobulin, assault, initial encounter
        • T50.Z13D Poisoning by immunoglobulin, assault, subsequent encounter
        • T50.Z13S Poisoning by immunoglobulin, assault, sequela
        • T50.Z14 Poisoning by immunoglobulin, undetermined
        • T50.Z14A Poisoning by immunoglobulin, undetermined, initial encounter
        • T50.Z14D Poisoning by immunoglobulin, undetermined, subsequent encounter
        • T50.Z14S Poisoning by immunoglobulin, undetermined, sequela
        • T50.Z15 Adverse effect of immunoglobulin
        • T50.Z15A Adverse effect of immunoglobulin, initial encounter
        • T50.Z15D Adverse effect of immunoglobulin, subsequent encounter
        • T50.Z15S Adverse effect of immunoglobulin, sequela
        • T50.Z16 Underdosing of immunoglobulin
        • T50.Z16A Underdosing of immunoglobulin, initial encounter
        • T50.Z16D Underdosing of immunoglobulin, subsequent encounter
        • T50.Z16S Underdosing of immunoglobulin, sequela
        • T50.Z9 Poisoning by, adverse effect of and underdosing of other vaccines and biological substances
        • T50.Z91 Poisoning by other vaccines and biological substances, accidental (unintentional)
        • T50.Z91A Poisoning by other vaccines and biological substances, accidental (unintentional), initial encounter
        • T50.Z91D Poisoning by other vaccines and biological substances, accidental (unintentional), subsequent encounter
        • T50.Z91S Poisoning by other vaccines and biological substances, accidental (unintentional), sequela
        • T50.Z92 Poisoning by other vaccines and biological substances, intentional self-harm
        • T50.Z92A Poisoning by other vaccines and biological substances, intentional self-harm, initial encounter
        • T50.Z92D Poisoning by other vaccines and biological substances, intentional self-harm, subsequent encounter
        • T50.Z92S Poisoning by other vaccines and biological substances, intentional self-harm, sequela
        • T50.Z93 Poisoning by other vaccines and biological substances, assault
        • T50.Z93A Poisoning by other vaccines and biological substances, assault, initial encounter
        • T50.Z93D Poisoning by other vaccines and biological substances, assault, subsequent encounter
        • T50.Z93S Poisoning by other vaccines and biological substances, assault, sequela
        • T50.Z94 Poisoning by other vaccines and biological substances, undetermined
        • T50.Z94A Poisoning by other vaccines and biological substances, undetermined, initial encounter
        • T50.Z94D Poisoning by other vaccines and biological substances, undetermined, subsequent encounter
        • T50.Z94S Poisoning by other vaccines and biological substances, undetermined, sequela
        • T50.Z95 Adverse effect of other vaccines and biological substances
        • T50.Z95A Adverse effect of other vaccines and biological substances, initial encounter
        • T50.Z95D Adverse effect of other vaccines and biological substances, subsequent encounter
        • T50.Z95S Adverse effect of other vaccines and biological substances, sequela
        • T50.Z96 Underdosing of other vaccines and biological substances
        • T50.Z96A Underdosing of other vaccines and biological substances, initial encounter
        • T50.Z96D Underdosing of other vaccines and biological substances, subsequent encounter
        • T50.Z96S Underdosing of other vaccines and biological substances, sequela